Progressive multifocal leukoencephalopathy in a patient with B-cell chronic lymphocytic leukemia after COVID-19 vaccination, complicated with COVID-19 and mucormycosis: a case report.
Autor: | Amirifard H; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.; Neurology, Iranian Center of Neurological Research, Tehran University of medical sciences, Imam Khomeini Hospital Complex, Tehran, Iran., Shahbazi M; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.; Neurology, Iranian Center of Neurological Research, Tehran University of medical sciences, Imam Khomeini Hospital Complex, Tehran, Iran., Farahmand G; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran., Ranjbar Z; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.; Neurology, Iranian Center of Neurological Research, Tehran University of medical sciences, Imam Khomeini Hospital Complex, Tehran, Iran., Kaeedi M; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.; Neurology, Iranian Center of Neurological Research, Tehran University of medical sciences, Imam Khomeini Hospital Complex, Tehran, Iran., Heydari Havadaragh S; Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran. sanazheydari400@gmail.com.; Neurology, Iranian Center of Neurological Research, Tehran University of medical sciences, Imam Khomeini Hospital Complex, Tehran, Iran. sanazheydari400@gmail.com. |
---|---|
Jazyk: | angličtina |
Zdroj: | BMC neurology [BMC Neurol] 2024 May 04; Vol. 24 (1), pp. 151. Date of Electronic Publication: 2024 May 04. |
DOI: | 10.1186/s12883-024-03650-y |
Abstrakt: | Background: Progressive multifocal leukoencephalopathy (PML) is a rare and fatal opportunistic viral demyelinating infectious disease of the central nervous system (CNS). There are various clinical presenting symptoms for the disease. Case Presentation: This paper presents a clinical case of PML in a patient with B-Chronic lymphocytic leukemia (B-CLL), previously treated with Chlorambucil, later complicated later with COVID-19 and mucormycosis. Conclusion: PML can develop in the setting of cellular immune dysfunction. Late diagnosis of this disease based on nonspecific symptoms is common, therefore when we face a neurological complication in a CLL or immunocompromised patient, we should consider PML infection. A remarkable feature of this case is the possible triggering effect of COVID-19 vaccination for emergence of PML as the disease can be asymptomatic or sub-clinical before diagnosis. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |